Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
SynKinase
I-BET762
114
CHF
CHF 114.00
In stock
SYN-3033-M0011 mgCHF 114.00
SYN-3033-M0055 mgCHF 170.00
SYN-3033-M01010 mgCHF 227.00
SYN-3033-M05050 mgCHF 639.00
SYN-3033-M100100 mgCHF 1'022.00
Product Details | |
---|---|
Synonyms | GSK-525762A |
Product Type | Chemical |
Properties | |
Formula | C22H22ClN5O2 |
MW | 423.9 |
CAS | 1260907-17-2 |
Purity Chemicals | ≥95% |
Appearance | Solid. |
Solubility | Soluble in DMSO. |
Declaration | Manufactured by SynKinase. |
Other Product Data | Target: BRD2, BRD3, and BRD4 | Kinase Group: N/A | Substrate: N/A |
InChi Key | AAAQFGUYHFJNHI-SFHVURJKSA-N |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
Documents | |
MSDS | Inquire |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
I-BET762 (GSK525762A) is an inhibitor for BET (bromodomain and extra terminal domain) proteins, BRD2, BRD3 and BRD4. It binds to the tandem bromodomains of BET with a Kd of 50.5-61.3nM, displaces a tetra-acetylated H4 peptide prebound to tandem bromodomains of BET with IC50 of 32.5-42.5nM in FRET analysis. I-BET762 disrupts the formation of the chromatin complexes essential for expression of inflammatory genes.
Product References
- Suppression of inflammation by a synthetic histone mimic: E. Nicodeme, et al.; Nature 468, 1119 (2010)
- Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors: H.S. Bandukwala, et al.; PNAS 109, 14532 (2012)